Point of Care Detection of Oral Pathogens
口腔病原体的即时检测
基本信息
- 批准号:8973923
- 负责人:
- 金额:$ 22.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-20 至 2017-08-19
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAntibodiesAntigensBacteriaBindingBiological AssayCandida albicansDetectionDevelopmentDevicesDiseaseEnsureFusobacteriumGenesHIVHIV-1Herpesvirus 1Human PapillomavirusInfectionLactobacillusMarketingMicrofluidic MicrochipsMorbidity - disease rateOral cavityOrganismPhasePorphyromonas gingivalisPrevotella intermediaProceduresProductionProtein MicrochipsProteinsProteomicsProtocols documentationProtozoaRouteSalivaSerotypingSimplexvirusStreptococcusStreptococcus mutansViral AntigensViral ProteinsVirusVirus Diseasesbasecost effectiveexperienceexpression vectorinfluenzavirusmalignant oropharynx neoplasmmortalityoral lesionoral pathogenpathogenpoint of careprototypepublic health relevancescreeningtransmission process
项目摘要
DESCRIPTION (provided by applicant): There are many pathogenic organisms that cause disease in the oral cavity or that can be detected there. Among these are three important viruses, human immunodeficiency virus (HIV), human papilloma virus (HPV) and herpes simplex virus (HSV). HIV infection and disease is treatable but is costly and is still associated with considerable morbidity and mortality. HPV is the primary cause of oropharyngeal cancer and HSV causes common oral lesions. All of these pathogens can be spread by contact with saliva. This is not a common route of transmission for HIV, but it is nevertheless a concern since HIV causes AIDS which is a fatal disease. It would therefore be desirable to have a simple, cost-effective point-of-care (POC) device for the detection of infection by HIV, HPV and HSV. We propose to use a protein microarray to detect HIV by antigen capture and to detect antibodies to each virus based on binding to viral proteins in the microarray. Antigen Discovery Incorporated (ADi) has considerable experience in the development, production and marketing of protein microarrays. We now sell seventeen reactive protein antigen microarrays from a variety of pathogenic viruses, bacteria and protozoa including an HIV-1 array with proteins from the five most common subtypes. Moreover, ADi has already isolated all the genes from eleven serotypes of HPV, HSV types 1 and 2 and inserted them into an expression vector for production of proteins. In order to develop a useful POC device for the detection of HIV as well as antibodies against HIV, HPV and HSV in saliva, we have the following specific aims for the first phase of this project: 1. Create a proteomic microarray containing all proteins from all common types of HIV-1, HPV and HSV. Later we will expand the microarray to include other oral pathogens 2. Develop a protocol for sensitive and specific screening for antibodies to oral pathogens in saliva using a proteomic microarray. In Phase II a microfluidic device will be developed to automate the assay procedure. 3. Develop a sensitive and specific microarray-based antigen-capture detection assay for HIV. In Phase II similar assays will be developed for HPV, HSV and other oral pathogens and the assay procedure will be automated using a microfluidic device.
描述(由申请人提供):有许多致病微生物会导致口腔疾病或在口腔中检测到。其中有三种重要的病毒,人类免疫缺陷病毒(HIV)、人类乳头瘤病毒(HPV)和单纯疱疹病毒(HSV)。艾滋病毒感染和疾病是可以治疗的,但费用昂贵,而且发病率和死亡率仍然很高。HPV是口咽癌的主要原因,HSV引起常见的口腔病变。所有这些病原体都可以通过接触唾液传播。这不是艾滋病毒的常见传播途径,但它仍然令人关切,因为艾滋病毒导致艾滋病,这是一种致命的疾病。因此,期望具有用于检测HIV、HPV和HSV感染的简单、成本有效的护理点(POC)装置。我们建议使用蛋白质微阵列检测艾滋病毒的抗原捕获和检测抗体的基础上结合到病毒蛋白的微阵列中的每一种病毒。Antigen Discovery Incorporated(ADI)在蛋白质微阵列的开发、生产和销售方面拥有丰富的经验。我们现在出售17种来自各种致病病毒、细菌和原生动物的反应蛋白抗原微阵列,包括一种含有五种最常见亚型蛋白质的HIV-1微阵列。此外,ADi已经从HPV、HSV 1型和2型的11种血清型中分离出所有基因,并将它们插入表达载体中用于生产蛋白质。为了开发一种用于检测唾液中的HIV以及针对HIV、HPV和HSV的抗体的有用的POC装置,本项目的第一阶段的具体目标如下:1.创建包含所有常见类型HIV-1、HPV和HSV的所有蛋白质的蛋白质组微阵列。稍后,我们将扩大微阵列,包括其他口腔病原体2。开发一种使用蛋白质组学微阵列对唾液中口腔病原体抗体进行敏感和特异性筛选的方案。在第二阶段,将开发一种微流体装置来自动化检测程序。3.开发一种灵敏、特异的基于微阵列的HIV抗原捕获检测方法。在第二阶段,将开发用于HPV、HSV和其他口腔病原体的类似检测方法,并且检测程序将使用微流体装置自动化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID CAMERINI其他文献
DAVID CAMERINI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID CAMERINI', 18)}}的其他基金
Identification of Serodiagnostic Epitopes for SARS-CoV-2, endemic HCoV?s and influenza virus
SARS-CoV-2、地方性 HCoV 和流感病毒血清诊断表位的鉴定
- 批准号:
10259177 - 财政年份:2021
- 资助金额:
$ 22.5万 - 项目类别:
Discovery of Yellow Fever Virus-Specific Epitopes for Development of an Accurate Serodiagnostic Assay
发现黄热病病毒特异性表位以开发准确的血清诊断测定
- 批准号:
9467246 - 财政年份:2018
- 资助金额:
$ 22.5万 - 项目类别:
Specific Detection of Antibodies to Emerging and Established Arboviruses Including Zika Virus
针对新出现和已建立的虫媒病毒(包括寨卡病毒)的抗体的特异性检测
- 批准号:
9347926 - 财政年份:2017
- 资助金额:
$ 22.5万 - 项目类别:
HIV Pathogenesis and Immunity in Viremic Non-Progressors
病毒血症非进展者的 HIV 发病机制和免疫
- 批准号:
8069963 - 财政年份:2010
- 资助金额:
$ 22.5万 - 项目类别:
HIV Pathogenesis and Immunity in Viremic Non-Progressors
病毒血症非进展者的 HIV 发病机制和免疫
- 批准号:
7931065 - 财政年份:2010
- 资助金额:
$ 22.5万 - 项目类别:
Defensin mediated inhibition of HIV-1 replication
防御素介导的 HIV-1 复制抑制
- 批准号:
6954219 - 财政年份:2004
- 资助金额:
$ 22.5万 - 项目类别:
Defensin mediated inhibition of HIV-1 replication
防御素介导的 HIV-1 复制抑制
- 批准号:
6845911 - 财政年份:2004
- 资助金额:
$ 22.5万 - 项目类别:
HIV-1 Clones with Attenuated Cytopathic Effects
细胞病变效应减弱的 HIV-1 克隆
- 批准号:
6744170 - 财政年份:2003
- 资助金额:
$ 22.5万 - 项目类别:
HIV-1 Clones with Attenuated Cytopathic Effects
细胞病变效应减弱的 HIV-1 克隆
- 批准号:
6655454 - 财政年份:2003
- 资助金额:
$ 22.5万 - 项目类别:
相似海外基金
Rationally guided discovery platform for monoclonal antibodies against carbohydrate antigens using virus-like particle conjugate immunization and high throughput selection
使用病毒样颗粒缀合物免疫和高通量选择的合理引导的针对碳水化合物抗原的单克隆抗体的发现平台
- 批准号:
10574738 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection
评估肝期抗原特异性抗体对抗恶性疟原虫肝期感染的作用
- 批准号:
10392870 - 财政年份:2021
- 资助金额:
$ 22.5万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
10092930 - 财政年份:2020
- 资助金额:
$ 22.5万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
9896170 - 财政年份:2020
- 资助金额:
$ 22.5万 - 项目类别:
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
使用进化遥远的海七鳃鳗结构独特的可变淋巴细胞受体抗体询问 B 谱系细胞上的细胞表面抗原
- 批准号:
433456 - 财政年份:2020
- 资助金额:
$ 22.5万 - 项目类别:
Operating Grants
Investigations of interactions between various natural antibodies and food-derived antigens
研究各种天然抗体与食物源性抗原之间的相互作用
- 批准号:
19K15765 - 财政年份:2019
- 资助金额:
$ 22.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identifying Kawasaki Disease-Specific Antibodies and Antigens
识别川崎病特异性抗体和抗原
- 批准号:
9932769 - 财政年份:2018
- 资助金额:
$ 22.5万 - 项目类别:
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
BB/P504713/1 - 财政年份:2017
- 资助金额:
$ 22.5万 - 项目类别:
Training Grant
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
1932904 - 财政年份:2017
- 资助金额:
$ 22.5万 - 项目类别:
Studentship
SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens
SBIR II 期:针对蛋白质和碳水化合物抗原的抗体的自动化设计方法
- 批准号:
1632399 - 财政年份:2016
- 资助金额:
$ 22.5万 - 项目类别:
Standard Grant